BACH1 and HIF1 alpha predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC)

Vladimirova V, Schneeweiss A, Jackisch C, Weber KE, Denkert C, Schmatloch S, Karn T, Fasching P, Braun S, Szeto C, Sinn B, Van Mackelenbergh M, Schem C, Stickeler E, Soon-Shiong P, Marme F, Mueller V, Untch M, Nekljudova V, Loibl S (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Annals of Oncology Elsevier

Publisher: ELSEVIER

City/Town: AMSTERDAM

Pages Range: S29-S29

Conference Proceedings Title: ANNALS OF ONCOLOGY

DOI: 10.1016/j.annonc.2021.03.035

Authors with CRIS profile

Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

GBG Forschungs GmbH (German Breast Group)

Germany (DE) Universitätsklinikum Heidelberg

Germany (DE) Sana Klinikum Offenbach

Germany (DE) Philipps-Universität Marburg

Germany (DE) Elisabeth-Krankenhaus

Germany (DE) Universitätsklinikum Frankfurt am Main (KGU)

Germany (DE) ImmunityBio Inc

United States (USA) (US) Charité - Universitätsmedizin Berlin

Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH)

Germany (DE) Mammazentrum Hamburg MVZ GbR

Germany (DE) Universitätsklinikum Aachen (UKA)

Germany (DE) Universitätsklinikum Mannheim

Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE)

Germany (DE) HELIOS Kliniken

Germany (DE)

How to cite

APA:

Vladimirova, V., Schneeweiss, A., Jackisch, C., Weber, K.E., Denkert, C., Schmatloch, S.,... Loibl, S. (2021). BACH1 and HIF1 alpha predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC). In ANNALS OF ONCOLOGY (pp. S29-S29). AMSTERDAM: ELSEVIER.

MLA:

Vladimirova, V., et al. "BACH1 and HIF1 alpha predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC)." Proceedings of the ANNALS OF ONCOLOGY AMSTERDAM: ELSEVIER, 2021. S29-S29.

BibTeX: Download